Australia
First Implants of Innovative Device Completed in the United States and Australia ShiraTronics, a clinical-stage innovator in neuromodulatio...
December 04, 2024 | News
Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics Enhances lab effic...
November 26, 2024 | News
-Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to m...
November 25, 2024 | News
Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Edith Cowan University Australia (ECU) announced a new strategic p...
November 20, 2024 | News
Telix Pharmaceuticals Limited announces it will expand its theranostic pipeline with new assets targeting Fibroblast Activation Protein (FAP), one of the m...
November 19, 2024 | News
Lixa, a Perth-based biotechnology company, has announced the launch of its first clinical trial to evaluate the safety and tolerability of NeoX-101, an inn...
November 14, 2024 | News
Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today an...
November 14, 2024 | News
Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral S...
November 12, 2024 | News
GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site...
November 12, 2024 | News
Fully automated SignalStar™ Multiplex IHC protocol on the BOND RX by Leica Biosystems eliminates hands-on time for streamlined image generation ...
November 05, 2024 | News
Telix Pharmaceuticals announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powere...
October 31, 2024 | News
Tessara Therapeutics, Psylo, and the University of Sydney are pleased to announce their receipt of a $3 million Cooperat...
October 29, 2024 | News
Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 in Australi...
October 28, 2024 | News
Telix Pharmaceuticals announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...
October 24, 2024 | News
Most Read
Bio Jobs
News